A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU

NCT05913336 PHASE1, PHASE2 COMPLETED

The purpose of this study is to evaluate the efficacy and safety of Remimazolam Tosilate for Injection for prolonged sedation(≥72h) during mechanical ventilation in the ICU.

Details

Lead sponsor	Jiangsu HengRui Medicine Co., Ltd.
Phase	PHASE1, PHASE2
Status	COMPLETED
Enrolment	24
Start date	Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Mar 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Sedation in the ICU

Interventions

• Remimazolam Tosilate

Countries

China